おすすめの製品
由来生物
mouse
品質水準
100
500
結合体
unconjugated
抗体製品の状態
culture supernatant
抗体製品タイプ
primary antibodies
クローン
OCH1E5, monoclonal
詳細
For In Vitro Diagnostic Use in Select Regions (See Chart)
フォーム
buffered aqueous solution
交差性
human
包装
vial of 0.1 mL concentrate (264M-94)
vial of 0.5 mL concentrate (264M-95)
bottle of 1.0 mL predilute (264M-97)
vial of 1.0 mL concentrate (264M-96)
bottle of 7.0 mL predilute (264M-98)
メーカー／製品名
Cell Marque®
テクニック
immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:100-1:500
アイソタイプ
IgG1κ
コントロール
liver
輸送温度
wet ice
保管温度
2-8°C
視覚化
cytoplasmic
詳細
Anti-hepatocyte specific antigen, also known as anti-Hep-Par1 (hepatocyte paraffin 1),recognizes both benign and malignant liver-derived tissues including such tumors ashepatocellular carcinoma. It recognizes both normal adult and fetal liver tissue. The typicalpattern is granular cytoplasmic staining. This antibody is useful in identifying hepatocellularcarcinomas.
品質
 IVD |  IVD |  IVD |  RUO |
関連事項
Hepatocyte Specific Antigen (Hep-Par1)(OCH1E5) Positive Control Slides, Product No. 264S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).
物理的形状
Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide
調製ノート
Download the IFU specific to your product lot and formatNote: This requires a keycode which can be found on your packaging or product label.
その他情報
For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com
法的情報
Cell Marque is a registered trademark of Merck KGaA, Darmstadt, Germany
適切な製品が見つかりませんか。
製品選択ツール.をお試しください
最新バージョンのいずれかを選択してください：
試験成績書（COA）
Lot/Batch Number
W M Tsui et al.
The American journal of surgical pathology, 23(1), 34-48 (1999-01-15)
Hepatic angiomyolipoma (AML) is frequently misdiagnosed. HMB-45 is a promising immunomarker for this tumor that leads to recognition of some AMLs with unusual morphology. The purpose of this collaborative study is to better define the morphologic variations of AML. Thirty
A Maitra et al.
American journal of clinical pathology, 115(5), 689-694 (2001-05-11)
Hepatocyte paraffin 1 (Hep Par 1) is a monoclonal antibody considered almost specific for normal and neoplastic hepatocytes, that can be used on formalin-fixed paraffin-embedded tissues. Hep Par 1 reactivity has been demonstrated consistently in hepatocellular carcinomas and hepatoblastomas but
M I Minervini et al.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 10(7), 686-692 (1997-07-01)
A monoclonal antibody highly specific for benign and malignant hepatocytes (HepPar 1) was evaluated as part of an antibody panel used to differentiate hepatocellular from nonhepatocellular neoplasms. Sixty-five liver tumors and two extrahepatic tumors from patients with documented liver tumors
M Fasano et al.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 11(10), 934-938 (1998-10-31)
The distinction of hepatoblastoma, especially the embryonal type, from other small, round-cell tumors of childhood can sometimes be difficult. Polyclonal anticarcinoembryonic antigen (pCEA) and Hepatocyte Paraffin 1 (Hep Par 1) are immunohistochemical markers that are useful in the diagnosis of
Peiguo G Chu et al.
The American journal of surgical pathology, 26(8), 978-988 (2002-08-10)
Hepatocyte monoclonal antibody (Hep) (alternatively Hep Par 1 for Hep paraffin 1) has been reported to stain normal hepatic tissue and hepatocellular carcinoma (HCC) with high specificity. We have studied the Hepatocyte expression in 96 cases of HCC and 311
資料
Colorectal cancer is the third most common cancer in both men and women. An estimated 136,000 cases of colorectal cancer are expected to occur in 2016.
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）